A safer medical needle
| Reference number | |
| Coordinator | Saga Surgical AB |
| Funding from Vinnova | SEK 900 000 |
| Project duration | April 2020 - April 2022 |
| Status | Completed |
| Venture | Innovative Startups |
| Call | Innovative Startups step 2 spring 2020 |
Important results from the project
** Denna text är maskinöversatt ** Xaga Surgical has invented and further developed a new type of medical needle that aims to reduce the risk of infection. Objective 1: Achieve technical objective with prototype - fulfilled Objective 2: Study on skin - fulfilled Objective 3: Marknadsundersökning USA - fulfilled.
Expected long term effects
** Denna text är maskinöversatt ** Our needle aims to be a better alternative than the needle for skin punctures with a risk of infection. In this project, we have taken great strides towards that goal. Our needle prototype is very well functioning, ready for production and the market research has offered us a faster path to the important US market, as well as insights around it. Tests on skin have confirmed a clearly reduced bacterial transport, results are intended to be published scientifically.
Approach and implementation
** Denna text är maskinöversatt ** It has been challenging times to implement this project. Covid has both directly affected us with sick employees but above all in production delays and travel bans. In combination with problems with global transportation, the lead time for prototypes has been a difficult challenge. We are very pleased to have managed to row this in port.